Latest News about SABS
Recent news which mentions SABS
12 Health Care Stocks Moving In Friday's After-Market Session
August 11, 2023
From Benzinga
EXCLUSIVE: SAB Biotherapeutics Says Diabetes Immunotherapy Shows Therapeutic Effect In Toxicology Study
June 21, 2023
Tickers
SABS
From Benzinga
From Benzinga
EXCLUSIVE: SAB Biotherapeutics' Influenza Immunotherapy Shows Safety, Efficacy In Early-Stage Trials
May 04, 2023
From Benzinga
EXCLUSIVE: SAB Biotherapeutics Releases Topline Data From Discontinued COVID Antibody Trial
April 26, 2023
From Benzinga
Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 19, 2023
From Benzinga
From Benzinga
Why Sonnet BioTherapeutics Shares Are Trading Lower By Around 13%; Here Are 20 Stocks Moving Premarket
April 19, 2023
From Benzinga
SAB Biotherapeutics Gets FDA Breakthrough Therapy Status On Influenza Treatment Candidate, Analysts Maintain Bullish Pitch
April 18, 2023
Tickers
SABS
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 18, 2023
From Benzinga
Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 18, 2023
From Benzinga
From Benzinga
EXCLUSIVE: SAB Biotherapeutics Secures FDA Breakthrough Therapy Tag For Its Influenza Immunotherapy
April 18, 2023
Tickers
SABS
From Benzinga
Why Teva Pharmaceutical Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 14, 2023
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 14, 2023
From Benzinga
Why Navidea Biopharmaceuticals Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
April 14, 2023
From Benzinga
From InvestorPlace
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 13, 2023
From Benzinga
Why ViewRay Shares Are Trading Lower By 32%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 13, 2023
From Benzinga
From Benzinga
From Benzinga
EXCLUSIVE: FDA Grants Expedited Review Status To SAB Biotherapeutics' Influenza Antibody
April 13, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 29, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Monday
March 27, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Friday
March 24, 2023
From Benzinga
EXCLUSIVE: SAB Biotherapeutics Receives Additional $8.2M In Closeout Of COVID-19 DoD Contract
January 18, 2023
Tickers
SABS
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.